TATA MEMORIAL CENTRE
ADVANCED CENTRE FOR TREATMENT, RESEARCH ANDEDUCATION IN CANCER
Kharghar,
Navi Mumbai- 410 210
No. ACTREC/ADVT-176/2024 04.11.2024
INTERVIEW FOR
SENIOR RESEARCH FELLOW
(ON PROJECT)
To work on project entitled “Profiling differential levels of chromatin modifiers and proteins
associated with histone biogenesis in breast cancer.”
EDUCATIONAL QUALIFICATION:
Essential: *M. Sc. in any Life Sciences related subjects with > 60% aggregate marks and having National
Level Exams conducted by Central Government Agencies and Institutions i.e. DST, DBT, DAE, DOS,
DRDO, MHRD, ICMR. IISC, ICAR, IISER etc.). The candidates without having National Level Exams
conducted by Central Government Agencies and Institutions will be considered with different salary.
WORK EXPERIENCE:
Essential: Two years of research experience in writing skill, data management, analytical skill,
laboratory work related to histopathological staining and molecular biology are essential.
*M.Sc. degree having a duration of one-year course will not be considered.
Selected candidates will have to join at the earliest; hence result-awaited candidates will not be eligible
to apply for the post.
CONSOLIDATED SALARY:
CSIR-UGC NET or GATE qualification - Rs. 35,000/- per month.
Without CSIR-UGC NET or GATE qualification: Rs. 25,000/- per month.
DURATION: Six Months.
The work progress of candidates will be monitored and extension after five months will depend on
satisfactory progress of the work.
Eligible Candidates may attend the walk-in interview on Thursday, 21st November, 2024 in Meeting Room-I,
3
rd Floor, Khanolkar Shodhika, ACTREC, Kharghar, Navi Mumbai -410210 along with recent CV and
photograph (passport size), original and xerox copies of all certificates (educational qualifications, work
experience, and Aadhaar Card as ID proof)
Reporting Time: 11.15 a.m. to 11.45 a.m.
In charge (Academic & Project Cell)
www.actrec.gov.in/sites/default/files/2024-11/Final%20Advt.-176-Senior%20Research%20Fellow..pdfSubscribe our X Channel Channel to get Latest and more updates: Join Now!
0 Comments